指南与共识重症综合管理与镇静镇痛呼吸衰竭与机械通气复苏、休克与脓毒症

危重癌症患者的复苏:比利时/法国学会共识会议

Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference.
指南 / 共识 · Intensive Care Med · 2021-09-20
一句话结论欧洲肺癌工作组与Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique召开共识会议,围绕危重癌症患者ICU分诊、呼吸支持、肾脏替代、血流动力学支持、心肺复苏、监测、输血及培训等九个预设问题形成共识。

该共识会议由欧洲肺癌工作组与Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique组织召开,旨在回应癌症患者入住ICU时应用有创监测与生命支持技术所引发的合理问题。方法学包括系统文献综述、专家意见及最终共识会议,围绕九个预设问题形成共识:ICU分诊标准、呼吸支持方式选择(高流量氧疗、无创通气、有创机械通气、体外膜氧合)、肾外净化支持、血流动力学支持、心肺复苏的获益、肿瘤治疗背景下的重症监测、ICU特定考虑、血液成分输注标准以及重症医生的培训要求。

要点

  • 共识会议围绕九个预设问题展开,涵盖危重癌症患者的ICU分诊、呼吸支持、肾脏替代、血流动力学支持、心肺复苏、监测、输血及培训。
  • 呼吸支持选项包括高流量氧疗、无创通气、有创机械通气和体外膜氧合,需根据并发症类型和环境选择。
  • 共识方法学包括系统文献综述、专家意见和最终共识会议。

研究设计与关键结果

  • 欧洲肺癌工作组与Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique召开共识会议,方法学包括系统文献综述、专家意见及最终共识会议。
  • 共识围绕九个预设问题形成:ICU分诊标准、呼吸支持方式选择、肾外净化支持、血流动力学支持、心肺复苏获益、肿瘤治疗背景下的重症监测、ICU特定考虑、血液成分输注标准及重症医生培训要求。

证据类型、等级与局限

  • 证据类型:共识会议(系统文献综述、专家意见及最终共识会议)。
  • 局限:原文未报告局限性

指南或共识出处

  • 危重癌症患者的复苏:比利时/法国学会共识会议(Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference),欧洲肺癌工作组与Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

To respond to the legitimate questions raised by the application of invasive methods of monitoring and life-support techniques in cancer patients admitted in the ICU, the European Lung Cancer Working Party and the Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique, set up a consensus conference. The methodology involved a systematic literature review, experts' opinion and a final consensus conference about nine predefined questions1. Which triage criteria, in terms of complications and considering the underlying neoplastic disease and possible therapeutic limitations, should be used to guide admission of cancer patient to intensive care units?2. Which ventilatory support [High Flow Oxygenation, Non-invasive Ventilation (NIV), Invasive Mechanical Ventilation (IMV), Extra-Corporeal Membrane Oxygenation (ECMO)] should be used, for which complications and in which environment?3. Which support should be used for extra-renal purification, in which conditions and environment?4. Which haemodynamic support should be used, for which complications, and in which environment?5. Which benefit of cardiopulmonary resuscitation in cancer patients and for which complications?6. Which intensive monitoring in the context of oncologic treatment (surgery, anti-cancer treatment …)?7. What specific considerations should be taken into account in the intensive care unit?8. Based on which criteria, in terms of benefit and complications and taking into account the neoplastic disease, patients hospitalized in an intensive care unit (or equivalent) should receive cellular elements derived from the blood (red blood cells, white blood cells and platelets)?9. Which training is required for critical care doctors in charge of cancer patients?

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Meert AP, Wittnebel S, Holbrechts S, et al. Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference. Intensive Care Med. 2021. PMID: 34545440. doi:10.1007/s00134-021-06508-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。